Friday, 29 March 2024
BioCryst Pharmaceuticals Inc.
NASDAQ : BCRX
13.53 14 Oct 22 00:00 | Change: 0.38 | Open: 14.20 | High: 14.50 | Ask: 8.09 | Volume: 1,631,400 |
Change(%): 2.73 | Prev: 13.91 | Low: 13.50 | Bid: 7.60 | Avg vol: 0 |
09:03 | 18/3/18
StockNewsTimes
BioCryst Pharmaceuticals logo Tekla Capital Management LLC boosted its holdings in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) by 39.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange ...
more»
07:11 | 18/3/18
MoneyMakingArticles
Venbio Select Advisor Llc decreased its stake in Biocryst Pharmaceuticals Inc (BCRX) by 8.96% based on its latest 2017Q3 regulatory filing with the SEC.
more»
04:56 | 16/3/18
Market Exclusive
BioCryst Pharmaceuticals, Inc. (BioCryst) is a biotechnology company. The Company designs, optimizes and develops small molecule drugs that block enzymes involved in the pathogenesis of diseases.
more»
Risk Alert: Before we dive into any analysis we simply note that BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) risk is elevated.
more»
02:30 | 15/3/18
Alpha Beta Stock
Wall Street's major indexes fell on Tuesday as uncertainty in Washington stemming from the dismissal of Secretary of State Rex Tillerson dragged down stocks across sectors.
more»
There are currently no comments on this topic.
Be the first person to Add a Comment...
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW
|
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |